Pfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.